Načítá se...

In vitro metabolism of misonidazole.

Misonidazole (MISO) is a nitroimidazole drug currently undergoing clinical trials as a radiosensitizer of hypoxic tumour cells. The drug is also toxic to such cells, probably because of metabolic activation of the nitro group under hypoxia. The metabolic fate of 14C-labelled MISO is examined, using...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Josephy, P. D., Palcic, B., Skarsgard, L. D.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1981
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010618/
https://ncbi.nlm.nih.gov/pubmed/7236487
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!